A cycloplatinated compound of p-isopropylbenzaldehyde thiosemicarbazone and its chloro-bridged derivative induce apoptosis in cis-DDP resistant cells which overexpress the H-ras oncogene

Journal of Inorganic Biochemistry

Volumn 73, Issue 4, 1999, Pages 235-243

  Pérez, José M ^a   Quiroga, Adoración G ^a   Montero, Eva I ^a   Alonso, C ^a   Navarro Ranninger, C ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Apoptosis; cis DDP; Cyclometallated compounds; Cytotoxicity; H ras

Indexed keywords

4 ISOPROPYLBENZALDEHYDE THIOSEMICARBAZONE DERIVATIVE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; GENE OVEREXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE RAS; STRUCTURE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CISPLATIN; DIMERIZATION; DRUG RESISTANCE, NEOPLASM; GENES, RAS; KERATINOCYTES; MICE; THIOSEMICARBAZONES;

EID: 0342467681     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00021-5     Document Type: Article

References (33)

1. Ellis R.E., Yuan J., Horvitz H.R. Annu. Rev. Cell Biol. 7:1991;663-698.
2. Steller H. Science. 267:1995;1445-1449.
3. Hickman J.A. Cancer Metastasis Rev. 11:1992;121-139.
4. C. Dive, A.H. Wyllie, in: J.A. Hickman, T.R. Tritton (Eds.), Frontiers in Pharmacology, Blackwell, Oxford, 1993, pp. 21-56.
5. Williams G.T. Cell. 65:1991;1-2.
6. Kerr J.F.R., Wyllie A.H., Currie A.R. Br. J. Cancer. 26:1972;239-257.
7. Arends M.J., Wyllie A.H. Int. Rev. Exp. Pathol. 32:1991;223-254.
8. A.H. Wyllie, J.F.R. Kerr, A.R. Currie, Cell death, the significance of apoptosisin, in: G.H. Bourne, F.J. Danielli, K.W Jeon (Eds.), Academic Press, New York. Int. Rev. Cytol. 8 (1980) 251-306.
9. O'Connor P.M., Kohn K.W. Semin. Cancer Biol. 3:1992;409-416.
10. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. Cell. 74:1993;957-967.
11. Sorenson C.M., Barry M.A., Eastman A. J. Natl. Cancer Inst. 82:1990;749-755.
12. Barry M.A., Behnke C.A., Eastman A. Biochem. Pharmacol. 40:1990;2353-2362.
13. Evans D.L., Dive C. Cancer Res. 53:1993;2133-2139.
14. K.W. Kohn, R.A.G. Ewig, L.C. Erickson, L.A. Zwelling, in: E.C. Friedberg, P.C. Hanawalt (Eds.), DNA Repair. A Laboratory Manual of Research Procedures, Part B, Marcel Dekker, New York, 1981, pp. 379-401.
15. Fichtinger-Schepman A.M.J., van der Veer J.L., den Hartog J.H.J., Lohman P.H.M., Reedjik J. Biochemistry. 24:1985;707-713.
16. Pinto A.L., Lippard S.J. Biochim. Biophys. Acta. 780:1985;167-180.
17. Eastman A. Cancer Cells. 2:1990;275-280.
18. Quiroga A.G., Pérez J.M., López-Solera I., Masaguer J.R., Luque A., Román P., Edwards A., Alonso C., Navarro-Ranninger C. J. Med. Chem. 41:1998;1399-1408.
19. Quiroga A.G., Pérez J.M., López-Solera I., Montero E.I., Masaguer J.R., Alonso C., Navarro-Ranninger C. J. Inorg. Biochem. 70:1998;117-124.
20. Dhara S.C. Indian J. Chem. 8:1970;193-194.
21. Sánchez-Prieto R., Vargas J.A., Carnero A., Marchetti E., Romero J., Durantez A., Lacal J.C., Ramón y Cajal S. Int. J. Cancer. 60:1995;235-243.
22. Tsuchida S., Sato K. Crit. Rev. Biochem. Mol. Biol. 27:1992;337-384.
23. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Cancer Res. 48:1998;589-601.
24. Jacobson M.D., Burne J.F., King M.P., Miyashita T., Reed J.C., Raff M.C. Nature. 361:1993;361-365.
25. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., Raff M.C. Cell. 48:1992;344-355.
26. Benito A., Silva M., Grillot D., Nuñez G., Fernández-Luna J.L. Blood. 87:1996;3837-3843.
27. Sumantran V.N., Ealovega M.W., Nuñez G., Clarke M.F., Wicha M.S. Cancer Res. 55:1995;2507-2510.
28. Aisner J., Lee J. Cancer. 67:1991;215-219.
29. Lipshultz S.E., Colan S.D., Gelber R.D., Pérez-Atayde A.R., Sallan S.E., Sanders S.P. New Engl. J. Med. 324:1991;808-812.
30. A.Y. Chang, in: W.P. McGuire, E.R. Rowinsky (Eds.), Paclitaxel in Cancer Treatment, Marcel Dekker, New York, 1995, pp. 273-279.
31. M. Leng, V. Bravec, in: K. Hemminki, A. Dipple, D.E.G. Smuker, F.F. Kadlubar, D. Segerbäck, H. Bartsch (Eds.), DNA Adducts, Identification and Biological Significance, International Agency for Research on Cancer, Lyon, 1994, pp. 339-348.
32. N. Farrel, in: R. Ugo, B.R. James (Eds.), Transition Metal Complexes as Drugs and Chemotherapeutic Agents, Kluwer, Boston, 1989, pp. 143-167.
33. McGrath J.D., Capon D., Goeddel D., Levinson A. Nature. 310:1984;644-655.